Coinbase
COIN
Strategy
MSTR
Tesla
TSLA
4
Salesforce
CRM
5
Meta Platforms
META
US Stock MarketDetailed Quotes
XFOR X4 Pharmaceuticals
- 0.320
- +0.016+5.16%
Trading Mar 11 11:55 ET
54.57MMarket Cap-4.00P/E (TTM)
0.325High0.296Low1.28MVolume0.308Open0.304Pre Close395.67KTurnover1.00%Turnover RatioLossP/E (Static)170.55MShares1.60052wk High0.91P/B41.04MFloat Cap0.26152wk Low--Dividend TTM128.24MShs Float23.930Historical High--Div YieldTTM9.63%Amplitude0.261Historical Low0.308Avg Price1Lot Size
About X4 Pharmaceuticals Company
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
Company Profile
SymbolXFOR
Company NameX4 Pharmaceuticals
Listing DateNov 16, 2017
Issue Price10.00
Founded2010
CEODr. Paula S. Ragan, PhD
MarketNASDAQ
Employees93
Fiscal Year Ends12-31
Address61 North Beacon Street,4th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02134
Phone1-857-529-8300
Websitehttp://www.x4pharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Paula S. Ragan, PhD
- Director, President and Chief Executive Officer
- 2.04M
- Arthur Taveras
- Chief Scientific Officer
- --
- Adam S. Mostafa
- Chief Financial Officer, Principal Accounting Officer, Treasurer and Corporate Secretary
- 1.15M
- Mark Baldy
- Chief Commercial Officer
- --
- Christophe Arbet-Engels
- Chief Medical Officer
- 1.64M
- Dr. Mary DiBiase, PhD
- Chief Operating Officer
- --
- Michael Stephen Wyzga
- Chairman of the Board
- 199.34K
- Dr. Gary J. Bridger, PhD
- Director
- 147.05K
- Dr. Murray W. Stewart, M.D.
- Director
- 90.08K
- Francoise de Craecker
- Independent Director
- 152.05K
- David W.J. McGirr, M.B.A.
- Independent Director
- 166.05K
- Alison F. Lawton
- Independent Director
- 154.55K
- Robert Keith Woods
- Independent Director
- 91.83K
- William E. Aliski
- Independent Director
- 165.05K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call